PDS Biotechnology Corporation (PDSB) Operating cash flow 2016–2025
PDS Biotechnology Corporation (PDSB) annual operating cash flow history from SEC filings — net cash provided by operating activities each fiscal year.
-$27.8MFY2025 · since FY2016: -$32.2M → -$27.8M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$27.8M | +20.8% |
| FY2024 | -$35.0M | -4.1% |
| FY2023 | -$33.6M | -30.8% |
| FY2022 | -$25.7M | -105.9% |
| FY2021 | -$12.5M | +5.0% |
| FY2020 | -$13.1M | +27.2% |
| FY2019 | -$18.1M | -1051.5% |
| FY2018 | -$1.6M | +96.1% |
| FY2017 | -$40.7M | -26.4% |
| FY2016 | -$32.2M | — |
Source: SEC XBRL filings · For reference only · Not investment advice